Lakhmir S Chawla
CIK 1646626 · Chief Medical Officer · last filed 2026-02-05
Lakhmir S Chawla is a Chief Medical Officer who has filed 61 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing shows the insider had shares withheld for taxes covering $4.2K of REVBW on Feb 5, 2026. Across all open-market trades the lifetime net is +$85.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $112 across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$112
2
61
$85.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| REVBW | Director | 12,158 | $0.01 | $112 | $0 | 4 | 2026-02-05 |
| LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Chief Medical Officer | 13,447 | $6.22 | $83.6K | $85.8K | 57 | 2020-09-17 |
Recent Filings
61 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-05 | REVBW | Tax (F) | −2,261 | -$4.2K | EDGAR |
| 2026-01-12 | REVBW | Grant (A) | +41,981 | $37.8K | EDGAR |
| 2025-10-31 | REVBW | Grant (A) | +15,625 | $20.0K | EDGAR |
| 2025-02-13 | REVBW | Grant (A) | +181 | $700 | EDGAR |
| 2020-09-17 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +286 | $1.1K | EDGAR |
| 2020-09-02 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +550 | $2.0K | EDGAR |
| 2020-08-18 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +589 | $2.0K | EDGAR |
| 2020-08-04 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +581 | $2.0K | EDGAR |
| 2020-07-17 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +521 | $2.0K | EDGAR |
| 2020-07-01 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +543 | $2.0K | EDGAR |